TrialDiabetes, obesity & metabolism2017

Reduction of postprandial glucose by lixisenatide vs sitagliptin treatment in Japanese patients with type 2 diabetes on background insulin glargine: A randomized phase IV study (NEXTAGE Study).

Yuichiro Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.